Free Trial

Arcadia Biosciences (RKDA) Insider Trading & Ownership

Arcadia Biosciences logo
$3.86 -0.33 (-7.88%)
(As of 11/14/2024 ET)

Arcadia Biosciences (NASDAQ:RKDA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.80%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$2,884.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get RKDA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arcadia Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RKDA Insider Buying and Selling by Quarter

Arcadia Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/1/2024Mark KawakamiCFOBuy700$2.06$1,442.00  
2/1/2024Thomas J SchaeferCFOBuy700$2.06$1,442.00  
(Data available from 1/1/2013 forward)

RKDA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Arcadia Biosciences includes Mark Kawakami, Pamela Haley, Stanley Jacot Jr, and Thomas J Schaefer. Learn more on insiders at RKDA.

1.80% of Arcadia Biosciences stock is owned by insiders. Learn more on RKDA's insider holdings.

The following insiders have purchased RKDA shares in the last 24 months: Mark Kawakami ($1,442.00), Stanley Jacot Jr ($21,550.00), and Thomas J Schaefer ($3,984.83).

Insiders have purchased a total of 7,749 RKDA shares in the last 24 months for a total of $26,976.83 bought.

Arcadia Biosciences Key Executives

  • Mr. Stanley E. Jacot Jr. (Age 53)
    President, CEO & Director
    Compensation: $527.9k
  • Mr. Thomas J. Schaefer (Age 48)
    CFO & Corporate Secretary
  • Mr. Tracy Baker
    Senior Vice President of Seamless Technical Operations


This page (NASDAQ:RKDA) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners